Holen Sie sich die Stockscreener-App
8.81
0.34%
0.03
Vorhandelsmarkt:
8.85
0.04
+0.45%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.78
Offen:
$8.76
24-Stunden-Volumen:
5.66M
Relative Volume:
2.40
Marktkapitalisierung:
$1.14B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-14.21
EPS:
-0.62
Netto-Cashflow:
$-29.73M
1W Leistung:
+31.49%
1M Leistung:
+70.74%
6M Leistung:
-11.81%
1J Leistung:
-46.67%
1-Tages-Spanne:
$8.55
$9.04
1-Wochen-Bereich:
$6.65
$9.06
52-Wochen-Spanne:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Firmenname
Neogenomics Inc
Sektor
Branche
Telefon
(239) 768-0600
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Vergleichen Sie NEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
8.81 | 1.13B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-29 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | Eingeleitet | Guggenheim | Neutral |
| 2025-04-30 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-12-10 | Eingeleitet | Jefferies | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-08-21 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-02-24 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-02-01 | Hochstufung | Needham | Hold → Buy |
| 2022-08-26 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-22 | Herabstufung | Needham | Buy → Hold |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-03-29 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-29 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | Fortgesetzt | Stephens | Overweight |
| 2021-12-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-25 | Fortgesetzt | Needham | Buy |
| 2021-02-25 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-12-11 | Fortgesetzt | BTIG Research | Buy |
| 2020-10-28 | Bestätigt | Needham | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-28 | Eingeleitet | Guggenheim | Buy |
| 2020-07-29 | Bestätigt | Needham | Buy |
| 2020-06-25 | Eingeleitet | BofA/Merrill | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Overweight |
| 2020-03-02 | Fortgesetzt | Craig Hallum | Buy |
| 2020-02-28 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-01 | Bestätigt | Needham | Buy |
| 2019-03-29 | Bestätigt | Needham | Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-10-24 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-02 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-08-24 | Eingeleitet | Gabelli & Co | Buy |
| 2016-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
Published on: 2025-09-03 06:21:26 - Newser
Has NeoGenomics Inc. found a price floorQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
What data driven models say about NeoGenomics Inc.’s futureMarket Trend Review & Safe Swing Trade Setup Alerts - Newser
Ranking NeoGenomics Inc. among high performing stocks via toolsGap Down & Free Long-Term Investment Growth Plans - Newser
Using Python tools to backtest NeoGenomics Inc. strategiesQuarterly Trade Report & Precise Trade Entry Recommendations - Newser
When is the best time to exit NeoGenomics Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - Newser
Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Is now a turning point for NeoGenomics Inc.2025 Support & Resistance & Fast Gain Swing Alerts - Newser
Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser
Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - خودرو بانک
Applying sector rotation models to NeoGenomics Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
What is NeoGenomics Inc. s debt to equity ratioJuly 2025 PostEarnings & High Win Rate Trade Tips - خودرو بانک
Is now a turning point for NeoGenomics IncIndex Update & Technical Pattern Based Buy Signals - Newser
NeoGenomics reports Q2 revenue of $181.3mln, net loss of $45.1mln. - AInvest
Fort Myers cancer lab firm wins federal patent lawsuit - Business Observer
Neogenomics shares fall 1.25% premarket after court rules in favor of patent invalidity. - AInvest
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
Applying big data sentiment scoring on NeoGenomics Inc.Dollar Strength & Risk Managed Investment Strategies - Newser
Does NeoGenomics Inc. meet Warren Buffett’s criteriaTrade Risk Summary & Daily Oversold Stock Bounce Ideas - خودرو بانک
Will NeoGenomics Inc. outperform the market in YEARVolume Spike & Daily Chart Pattern Signals - خودرو بانک
Real time social sentiment graph for NeoGenomics Inc.July 2025 Levels & Risk Adjusted Swing Trade Ideas - Newser
Why is NeoGenomics Inc. stock going upCPI Data & Fast Entry Momentum Trade Alerts - خودرو بانک
Technical Charts Suggest Momentum Shift in CCRN getLinesFromResByArray error: size == 0 - kangso.co.kr
Full technical analysis of NeoGenomics Inc. stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
NeoGenomics rallies after court win in Natera patent dispute - MSN
Applying big data sentiment scoring on NeoGenomics IncWeekly Trade Recap & High Conviction Investment Ideas - Newser
Neogenomics Soars 21.64% on Legal Victory, Cancer Diagnostics Dominance - AInvest
Is a relief rally coming for NeoGenomics Inc. holdersJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
How to interpret RSI for NeoGenomics Inc. stockMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
What’s next for NeoGenomics Inc. stock priceEarnings Recap Summary & Short-Term High Return Strategies - Newser
Can NeoGenomics Inc. rally from current levels2025 Retail Activity & Daily Momentum Trading Reports - Newser
Has NeoGenomics Inc. formed a bullish divergenceGap Down & Weekly Setup with High ROI Potential - Newser
Signal strength of NeoGenomics Inc. stock in tech scannersInsider Selling & Fast Gain Swing Alerts - Newser
Automated trading signals detected on NeoGenomics Inc.July 2025 Trends & Consistent Profit Trade Alerts - Newser
Analysts Backtest Strategies on NeoGenomics Inc. With Promising Results getLinesFromResByArray error: size == 0 - thegnnews.com
NeoGenomics Sees Price Target Reduced Amidst Steady Optimism - StocksToTrade
NeoGenomics Inc. stock outlook for YEARPortfolio Profit Report & Fast Gain Swing Alerts - Newser
Can swing trading help recover from NeoGenomics Inc. lossesTrade Exit Summary & Low Risk High Win Rate Picks - Newser
Can NeoGenomics Inc. deliver alphaWeekly Stock Recap & Fast Gain Swing Trade Alerts - sundaytimes.kr
Can volume confirm reversal in NeoGenomics Inc.2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Finanzdaten der Neogenomics Inc-Aktie (NEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):